Ergoline derivatives. Note XIII (1) alpha-adrenergic blocking drugs. 1975

L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser

The synthesis and the pharmacological activities of 24 analogues of the alpha-adrenergic blocking drug, nicergoline (I b), are reported. The majority of the new compounds were found to be less active than (I b): the structure-activity relationships are presented and discussed.

UI MeSH Term Description Entries
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D009530 Nicergoline An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It may ameliorate cognitive deficits in CEREBROVASCULAR DISORDERS. Nimergoline,Circo-Maren,Ergobel,F.I. 6714,Fisifax,Nicergobeta,Nicergolin Atid,Nicergolin Lindo,Nicergolin Von Ct,Nicergolin-Neuraxpharm,Nicergolin-Ratiopharm,Nicergolin-TEVA,Nicerium,Nicotergoline,Sermion,Circo Maren,Nicergolin Neuraxpharm,Nicergolin Ratiopharm,Nicergolin TEVA,Von Ct, Nicergolin
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D000317 Adrenergic alpha-Antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Adrenergic alpha-Receptor Blockaders,alpha-Adrenergic Blocking Agents,alpha-Adrenergic Receptor Blockaders,alpha-Blockers, Adrenergic,Adrenergic alpha-Blockers,alpha-Adrenergic Antagonists,alpha-Adrenergic Blockers,Adrenergic alpha Antagonists,Adrenergic alpha Blockers,Adrenergic alpha Receptor Blockaders,Agents, alpha-Adrenergic Blocking,Antagonists, alpha-Adrenergic,Blockaders, Adrenergic alpha-Receptor,Blockaders, alpha-Adrenergic Receptor,Blockers, alpha-Adrenergic,Blocking Agents, alpha-Adrenergic,Receptor Blockaders, alpha-Adrenergic,alpha Adrenergic Antagonists,alpha Adrenergic Blockers,alpha Adrenergic Blocking Agents,alpha Adrenergic Receptor Blockaders,alpha Blockers, Adrenergic,alpha-Antagonists, Adrenergic,alpha-Receptor Blockaders, Adrenergic

Related Publications

L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
July 1994, Drug safety,
L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
January 1999, Journal of clinical pharmacology,
L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
July 1995, British journal of urology,
L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
November 1980, Journal of medicinal chemistry,
L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
January 1983, Circulatory shock,
L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
November 1967, JAMA,
L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
September 1981, Molecular pharmacology,
L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
December 1948, The Journal of pharmacology and experimental therapeutics,
L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
January 1971, British medical journal,
L Bernardi, and G Bosisio, and C Elli, and B Patelli, and A Temperilli, and G Arcari, and H A Glaesser
January 1985, Annual review of medicine,
Copied contents to your clipboard!